Smith & Nephew SNATS Inc. (SNN) — RQD Stock Rating Cockpit

Per the Roarable RQD rating, SNN scores 58 out of 100, graded D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 11 / 20 (ROIC 9.9%; FCF yield 2.21%), Whale 13F Flow at 11 / 20 (institutional accumulation and options positioning), Insider Conviction at 12 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 8 / 20 (Beta 1.03; sector sensitivity), and Forensic Balance Sheet at 16 / 20 (Altman Z 3.74; Piotroski F 8/9; Debt/Equity 0.39). The strongest pillar is the forensic balance sheet, which indicates low measured balance-sheet risk. The weakest are macro regime fit and the cash engine: the rating's own inputs show a modest ROIC and a thin free-cash-flow yield relative to a P/E (TTM) of 32.8, meaning the valuation leaves limited cushion if cash generation does not expand. Insider and institutional pillars are mid-range and do not offer a clear counterweight in the supplied data. For a prospective investor, the evidence points to a financially sound issuer priced at a premium multiple, where upside depends on earnings and cash-flow growth that the rating does not confirm. This is an analytical summary of the rating's components, not personalized financial advice.

Per the recent news section, six items were reported, with signal labels as follows:

• CATALYST (GREEN): a report covering SNN market action, institutional positioning, and fundamental catalysts.
• RISK WATCH (RED): a report titled around disciplined, rules-based execution in response to SNN.
• MARKET WIRE (YELLOW): four items, covering a CARTIHEAL implant launch across European markets, a technical-level price report referencing $30.83 and $29.29, a competitor listing for Teleflex, and a report on a new USD 700 million bond reshaping the debt profile.

The bond item is the most fundamentally relevant headline, since it bears on the balance-sheet pillar, but the headline alone does not state terms, maturities, or use of proceeds. Several items have weak source attribution (one labeled with a government domain, one with a generic site name), so they should be treated as unverified. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded.

• What are the company's revenue, operating income, net income, and free cash flow across reported periods? The financials section is empty, so the earnings trajectory behind the 32.8 TTM P/E cannot be verified.
• What are the terms, maturity, and use of proceeds for the reported USD 700 million bond, and how does it change leverage?
• Why is gross margin reported as 0%, and is that a data gap or an accounting presentation issue?
• What is the consensus analyst rating and price target, given that the analyst section is empty?
• Who are the institutional and insider holders, and what is the direction of their recent activity, given that the holders section is empty?